A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines. Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system. We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit™. Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities. Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities. These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of defined culture media with recombinant proteins instead of whole animal serum greatly increases process comparability and supply chain assurance [67,68,69].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene-modified therapies, including iPSC-derived products and CAR-T cells, present distinct biosafety and technical challenges for POC implementation (Nakagawa et al., 2014; Moradi et al., 2023).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Nakagawa et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · cited 3×
“Moreover, hiPSCs were successfully established from primary fibroblasts, peripheral blood and cord blood under these conditions using episomal vectors 16,17 .”
BackgroundMethodA ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 2×
“In addition, it is necessary to use defined culture system for the source of iPS cells, such as fibroblasts or blood cells 13,23 .”
BackgroundMethodEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Research works printed but not linked: 1
- Grigoriadis, A. E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). · DOI · Paper page
Cited by
Items 201–300 of 675
Imai, R., Tamura, R., Yo, M., Sato, M., Fukumura, M., Takahara, K., Kase, Y., Okano, H., & Toda, M. (2023) · Stem Cells · doi:10.1093/stmcls/sxad028 · Cited by 31
Lee, K.-I., Kim, H.-T., & Hwang, D. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.059 · Cited by 25
iPS Cells—The Triumphs and Tribulations
Sharma, R. (2016) · Dentistry Journal · doi:10.3390/dj4020019 · Cited by 27
“Another method for generation and maintenance culture of iPSCs that are suitable for use in cell transplantation therapy has been recently developed [33].”
MethodHashimoto, R., Tamura, T., Watanabe, Y., Sakamoto, A., Yasuhara, N., Ito, H., Nakano, M., Fuse, H., Ohta, A., Noda, T., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00114 · Cited by 23
Derivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata)
Nakai, R., Ohnuki, M., Kuroki, K., Ito, H., Hirai, H., Kitajima, R., Fujimoto, T., Nakagawa, M., Enard, W., & Imamura, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30734-w · Cited by 26
Mitsuzawa, S., Ikeguchi, R., Aoyama, T., Ando, M., Takeuchi, H., Yurie, H., Oda, H., Noguchi, T., Ohta, S., Zhao, C., et al. (2019) · Microsurgery · doi:10.1002/micr.30507 · Cited by 24
“…of iMSCs from iPSCs (a feeder-free iPSC line, 625D4) through neural crest cells (NCCs) was performed as described previously (Fukuta et al., 2014; Nakagawa et al., 2014; Oceguera-Yanez et al., 2016) (Figure 1a,b). iMSCs at passage four were incubated with CD45-APC, CD73-PE, CD44-PE (Becton…”
MethodShiba, T., Tanaka, T., Ida, H., Watanabe, M., Nakaseko, H., Osawa, M., Shibata, H., Izawa, K., Yasumi, T., Kawasaki, Y., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.039 · Cited by 24
Immunological Properties of Neural Crest Cells Derived from Human Induced Pluripotent Stem Cells
Fujii, S., Yoshida, S., Inagaki, E., Hatou, S., Tsubota, K., Takahashi, M., Shimmura, S., & Sugita, S. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0058 · Cited by 23
“The iPSCs were cultured under feeder-free and serum-free conditions with AK03N medium (Ajinomoto, Tokyo, Japan) in six-well culture plates coated with iMatrix-511 (Nippi, Tokyo, Japan) as previously described [29].”
MethodLaminins in osteogenic differentiation and pluripotency maintenance
Chen, C., Jiang, Z., & Yang, G. (2020) · Differentiation · doi:10.1016/j.diff.2020.05.002 · Cited by 24
Li, Q., Qi, G., Liu, X., Bai, J., Zhao, J., Tang, G., Zhang, Y. S., Chen-Tsai, R. Y., Zhang, M., Wang, D., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104046 · Cited by 26
Xu, H., Kita, Y., Bang, U., Gee, P., & Hotta, A. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100965 · Cited by 26
Miki, T., Wong, W., Zhou, E. K., Gonzalez, A., Garcia, I. M., & Grubbs, B. H. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0258-z · Cited by 23
Duncan, G., Firth, K., George, V. T., Hoang, M. D., Staniforth, A., Smith, G. L., & Denning, C. N. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0172 · Cited by 29
“Cultures were routinely passaged at a ratio of 1:8 (*20,000 cells/cm(2)) and harvested 3 days later, equating to a population doubling rate of *24–27 h, which is consistent with the wider literature [16].”
MethodTamura, R., Miyoshi, H., Morimoto, Y., Oishi, Y., Sampetrean, O., Iwasawa, C., Mine, Y., Saya, H., Yoshida, K., Okano, H., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.326 · Cited by 24
Yamane, M., Takaoka, N., Obara, K., Shirai, K., Aki, R., Hamada, Y., Arakawa, N., Hoffman, R. M., & Amoh, Y. (2021) · Cells · doi:10.3390/cells10040864 · Cited by 25
“[25] demonstrated that human embryonic stem cells and hiPSC, cultured in xeno-free medium, could differentiate to dopaminergic neurons.”
BackgroundAmimoto, N., Nishimura, K., Shimohama, S., & Takata, K. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102486 · Cited by 26
A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome
Takeda, Y., Ueki, M., Matsuhiro, J., Walinda, E., Tanaka, T., Yamada, M., Fujita, H., Takezaki, S., Kobayashi, I., Tamaki, S., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231941 · Cited by 22
“The generation of iPSCs from the patient was performed as described previously (Nakagawa et al., 2014).”
Proteasome impairment in neural cells derived from HMSN-P patient iPSCs
Murakami, N., Imamura, K., Izumi, Y., Egawa, N., Tsukita, K., Enami, T., Yamamoto, T., Kawarai, T., Kaji, R., & Inoue, H. (2017) · Molecular Brain · doi:10.1186/s13041-017-0286-y · Cited by 23
Hashizume, R., Wakita, S., Sawada, H., Takebayashi, S., Kitabatake, Y., Miyagawa, Y., HIROKAWA, Y. S., Imai, H., & Kurahashi, H. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf022 · Cited by 36
USP10 Inhibits Aberrant Cytoplasmic Aggregation of TDP-43 by Promoting Stress Granule Clearance
Takahashi, M., Kitaura, H., Kakita, A., Kakihana, T., Katsuragi, Y., Onodera, O., Iwakura, Y., Nawa, H., Komatsu, M., & Fujii, M. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00393-21 · Cited by 24
“Human iPSCs (clone1231A3) (63) were obtained from Riken BioResource Research Center (BRC).”
MethodMishima, T., Ishikawa, T., Imamura, K., Kondo, T., Koshiba, Y., Takahashi, R., Takahashi, J. A., Watanabe, A., Fujii, N., Tsuboi, Y., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.06.007 · Cited by 21
Inoue, Y., Kishida, T., Kotani, S., Akiyoshi, M., Taga, H., Seki, M., Ukimura, O., & Mazda, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-50388-6 · Cited by 23
Kakihana, T., Takahashi, M., Katsuragi, Y., Yamashita, S., Sango, J., Kanki, T., Onodera, O., & Fujii, M. (2021) · iScience · doi:10.1016/j.isci.2021.102733 · Cited by 20
Nakashima, Y., & Tsukahara, M. (2022) · Stem Cells and Development · doi:10.1089/scd.2022.0010 · Cited by 23
“In 2016, a new type of induced pluripotent stem cell (iPSC) culture medium (named StemFit) [1] was developed in a joint venture between Professor Yamanaka of Kyoto University (the creator of iPSCs) and Ajinomoto Co.”
BackgroundMethodInfluentialKawada, R., Jonouchi, T., Kagita, A., Sato, M., Hotta, A., & Sakurai, H. (2023) · Scientific Reports · doi:10.1038/s41598-022-26614-z · Cited by 21
Freude, K., Pires, C., Hyttel, P., & Hall, V. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041402 · Cited by 22
“Together, these mentioned advances in production of human iPS cells might allow research to fulfill the restricted guidelines of Good Manufacturing Practices (GMPs) for the development of clinically-approved iPS cells required in the regenerative medicine field [70].”
BackgroundSamata, B., Kikuchi, T., Miyawaki, Y., Morizane, A., Mashimo, T., Nakagawa, M., Okita, K., & Takahashi, J. A. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.01.027 · Cited by 20
Wen, W., Zhang, J., Chen, W., Arakaki, C., Li, X., Baylink, D. J., Botimer, G. D., Xu, J., Yuan, W., Cheng, T., et al. (2017) · Journal of Visualized Experiments · doi:10.3791/55091 · Cited by 22
Miyamoto, Y., Ikeuchi, M., Noguchi, H., Yagi, T., & Hayashi, S. (2017) · Cell Medicine · doi:10.3727/215517916x693096 · Cited by 23
Nishiuchi, R., Li, S., Ebisu, F., & Sekiguchi, K. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.08.001 · Cited by 20
“Furthermore, the laminin-511 E8 fragment (designated LM511E8) supports robust adhesion and expansion of dissociated human ES and induced pluripotent stem (iPS) cells [19,20].”
BackgroundMethodResultInfluentialOtomo, N., Takeda, K., Kawai, S., Kou, I., Guo, L. Z., Osawa, M., Alev, C., Kawakami, N., Miyake, N., Matsumoto, N., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105920 · Cited by 20
Numerical operations in living cells by programmable RNA devices
Endo, K., Hayashi, K., & Saito, H. (2019) · Science Advances · doi:10.1126/sciadv.aax0835 · Cited by 21
“Upon spontaneous differentiation ( 26 ), 3000 hiPSCs were seeded on iMatrix-511–coated six-well plates and cultured in StemFit AK03N without bFGF for 14 days.”
MethodYoon, Y., Kim, H. S., Hong, C. P., Li, E., Jeon, I., Park, H. J., Lee, N., Pei, Z., & Song, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.558204 · Cited by 19
“Preparation of Neural Precursor Cells Derived From Induced Pluripotent Stem Cells (1231A3-NPCs) The 1231A3 human iPSC line, originally generated from peripheral blood mononuclear cells (PBMCs) using episomal vectors (Nakagawa et al., 2014), was provided by the Center for iPS cell Research and Application (CiRA) at Kyo…”
BackgroundMethodGeneration of region-specific and high-purity neurons from human feeder-free iPSCs
Sato, T., Imaizumi, K., Watanabe, H., Ishikawa, M., & Okano, H. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135676 · Cited by 22
Miyagi‐Shiohira, C., Kobayashi, N., Saitoh, I., Watanabe, M., Noguchi, Y., Matsushita, M., & Noguchi, H. (2016) · Cell Medicine · doi:10.3727/215517916x693122 · Cited by 19
Song, D., Takahashi, G., Zheng, Y., Matsuo‐Takasaki, M., Li, J., Takami, M., An, Y., Hemmi, Y., Miharada, N., Fujioka, T., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac080 · Cited by 22
“A feeder-free culture system was used to culture all of the iPSC lines (59).”
Guerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 21
“hIPSCs used for research are usually generated and maintained on feeder cells, while hIPSCs destined for clinical use should be kept in feeder-free (Ff) and xeno-free (free of foreign species) (Xf) culture conditions [174].”
Taga, S., Suga, H., Nakano, T., Kuwahara, A., Inoshita, N., Kodani, Y., Nagasaki, H., Sato, Y., Tsumura, Y., Sakakibara, M., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.002 · Cited by 25
“Ff method for differentiation of hPSCs into PHOs Ff-hPSCs maintained and cultured on LM511-E8 matrix in StemFit medium (Nakagawa et al., 2014) were examined for pituitary and hypothalamus differentiation in serumfree floating culture of embryoid body-like aggregates using the quick reaggregation (SFEBq) method (Eiraku…”
Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress
恩田, 亜., Hasegawa-Ogawa, M., Matsuno, H., Shiraishi, T., Bono, K., Hiraki, H., Kanegae, Y., Iguchi, Y., & Okano, H. J. (2023) · Molecular Brain · doi:10.1186/s13041-023-01050-w · Cited by 22
“0; Life Technologies, D-PBS(-); FUJIFILM WAKO) [51, 52].”
Tsujimoto, H., Hoshina, A., Mae, S.-I., Araoka, T., Changting, W., Ijiri, Y., Nakajima‐Koyama, M., Sakurai, S., Okita, K., Mizuta, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113602 · Cited by 18
Matsumura, T., Tatsumi, K., Noda, Y., Nakanishi, N., Okonogi, A., Hirano, K., Li, L., Osumi, T., Tada, T., & Kotera, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.081 · Cited by 18
Genotoxic Effects of Culture Media on Human Pluripotent Stem Cells
Bangalore, M. P., Adhikarla, S., Mukherjee, O., & Panicker, M. M. (2017) · Scientific Reports · doi:10.1038/srep42222 · Cited by 21
Ghoubay, D., de Sousa, C., Martos, R., Latour, G., Schanne‐Klein, M., Dupin, É., & Borderie, V. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188398 · Cited by 20
Gupta, N. R., Susa, K., Yoda, Y., Bonventre, J. V., Valerius, M. T., & Morizane, R. (2018) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.50 · Cited by 21
“Each hPSC line is derived from a single parent cell, with theoretically isogenic progeny, made possible using a feeder-free culture system that allows for single cell plating (Nakagawa et al., 2014).”
BackgroundInfluentialNakamura, Y., Shimizu, Y., Horibata, Y., Tei, R., Koike, R., Masawa, M., Watanabe, T., Shiobara, T., Arai, R., Chibana, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09980-x · Cited by 19
Kuroda, T., Ando, S., Takeno, Y., Kishino, A., & Kimura, T. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101514 · Cited by 20
Morita, S., Kondo, T., Tokuda, H., Kaneda, Y., Izumo, T., Nakao, Y., & Inoue, H. (2025) · iScience · doi:10.1016/j.isci.2025.112557 · Cited by 22
Otsuka, Y., Imamura, K., Oishi, A., Asakawa, K., Kondo, T., Nakai, R., Suga, M., Inoue, I., Sagara, Y., Tsukita, K., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174179 · Cited by 19
Alsayegh, K. N., Matsuura, K., Sekine, H., & Shimizu, T. (2017) · Scientific Reports · doi:10.1038/srep45577 · Cited by 17
Nakanishi, H., Lee, J.-K., Miwa, K., Masuyama, K., Yasutake, H., Li, J., Tomoyama, S., Honda, Y., Deguchi, J., Tsujimoto, S., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00818 · Cited by 20
“In addition, it has been reported in clinical setting that atrial alternans in action potentials is a risk factor of AF (Narayan et al., 2002).”
BackgroundTogo, K., Fukusumi, H., Shofuda, T., Ohnishi, H., Yamazaki, H., Hayashi, M. K., Kawasaki, N., Takei, N., Nakazawa, T., Saito, Y., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00851-1 · Cited by 21
“Cell lines We used two hiPSC lines, 1210B2 and 1201C1 [22, 23], which were established from peripheral mononuclear blood cells using an integration-free reprogramming method and a feeder-free protocol (1210B2) [24] or SNL research.”
MethodZhang, D., Mai, Q., Li, T., Huang, J., Ding, C., Jia, M., Zhou, C., & Xu, Y. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0347-7 · Cited by 18
“Therefore, it is highly desirable to employ defined components rather than complex mixtures [32–35].”
Chiu, Y.-S., Wang, K.-L., & Wu, K.-L. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1644318 · Cited by 17
Miyamoto, Y. (2023) · Gels · doi:10.3390/gels9040321 · Cited by 18
“Therefore, laminin is attracting attention as a feederfree culture substrate for human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) [53].”
BackgroundZheng, Y., Ji, S., Wu, H., Tian, S., Wang, X., Luo, P., He, F., Wang, Z., Wang, J., Wang, Z., et al. (2015) · PubMed Central · Cited by 19
Stem Cell Therapy for Parkinson’s Disease
Han, F., & Hu, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_3 · Cited by 18
Fliefel, R. M., Ehrenfeld, M., & Otto, S. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2697 · Cited by 19
“Various matrices can be used to replace feeder cells such as Matrigel, extracellular matrix proteins, or synthetic polymers (Lee, Kim, et al., 2016; Nakagawa et al., 2014).”
BackgroundSohi, A. N., Naderi‐Manesh, H., Soleimani, M., Yasaghi, E. R., Manjili, H. K., Tavaddod, S., & Nojehdehi, S. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.072 · Cited by 18
Hawkins, K., & Duchen, M. R. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i5.236 · Cited by 18
Yu, L., Yong, Y., Zhang, B., Bai, X., Fei, Q., & Zhang, L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29788 · Cited by 17
“Feeder‐free iPSCs (Y00275) (provided by Takara) were established from human peripheral blood mononuclear as reported previously (Nakagawa et al., 2014).”
MethodEdo, A., Sugita, S., Futatsugi, Y., Sho, J., Onishi, A., Kiuchi, Y., & Takahashi, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217831 · Cited by 18
Liu, Y.-C., Ban, L.-K., Lee, H. H., Lee, H.-T., Chang, Y., Lin, Y., Su, H., Hsu, S.-T., & Higuchi, A. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01878g · Cited by 17
MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control
Masaki, K., Fujita, Y., & Saito, H. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102609 · Cited by 22
Microwell bag culture for large-scale production of homogeneous islet-like clusters
Suenaga, R., Konagaya, S., Yamaura, J., Ito, R., Tanaka, S., Ishizaki, Y., & Toyoda, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-09124-w · Cited by 19
Ura, H., Togi, S., & Niida, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-14902-7 · Cited by 25
Culturing human pluripotent stem cells for regenerative medicine
Ozawa, H., Matsumoto, T., & Nakagawa, M. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2225701 · Cited by 20
“It allows for a higher split ratio in a single-cell manner, demonstrating the advantages of using albumin to enhance cell culture performance [63].”
BackgroundMutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation
Suzuki, H., Egawa, N., Imamura, K., Kondo, T., Enami, T., Tsukita, K., Suga, M., Yada, Y., Shibukawa, R., Takahashi, R., et al. (2024) · Molecular Brain · doi:10.1186/s13041-024-01086-6 · Cited by 17
Cheng, K., Seita, Y., Whelan, E. C., Yokomizo, R., Hwang, Y. S., Rotolo, A., Krantz, I. D., Ginsberg, J. P., Kolon, T. F., Lal, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114323 · Cited by 16
Kimura, Y., Kasai, K., & MIYATA, S. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.06.053 · Cited by 21
Futaki, S., Nakano, I., Kawasaki, M., Sanzen, N., & Sekiguchi, K. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.04.010 · Cited by 17
“[27] reported that endodermal cells derived from mouse embryonic stem cells spread on fibronectin and formed typical focal adhesions, a complex of cell adhesion molecules including integrin a5b1.”
BackgroundMethodSugawara, Y., Hamada, K., Yamada, Y., Kumai, J., Kanagawa, M., Kobayashi, K., Toda, T., Negishi, Y., Katagiri, F., Hozumi, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49669-x · Cited by 16
Villa-Diaz, L. G., Kim, J. K., Lahann, J., & Krebsbach, P. H. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0087 · Cited by 17
Cell Therapy for Parkinson’s Disease
Morizane, A., & Takahashi, J. B. (2016) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2015-0303 · Cited by 17
Sekine, S.-I., Nishii, K., Masaka, T., Kurita, H., Inden, M., & Hozumi, I. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.096 · Cited by 16
Mechanisms of human germ cell development
Saitou, M., Nagano, M., & Mizuta, K. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00893-6 · Cited by 20
“This discrepancy might be attributable to the hiPSC culture conditions used, which maintained the primed pluripotent state in a robust manner 68 and thus prolonged the exit from this state, or could be due to the iMeLC induction condition with knockout serum replacement (KSR), as serum-free media…”
Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion
Du, S., Tay, J. C.-K., Chen, C., Tay, F. C., Tan, W.-K., Li, Q., & Wang, S. (2015) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.12.009 · Cited by 15
Kim, M., Thanuthanakhun, N., Fujimoto, S., & Kino‐oka, M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102534 · Cited by 19
Matsumoto, T., Kim, M.-H., & Kino-oka, M. (2022) · Bioengineering · doi:10.3390/bioengineering9110613 · Cited by 12
“The general culture method that hiPSCs were maintained with Y-27632 for 24 h was defined as short-term exposure to ROCK inhibitor to prevent apoptosis of single-dissociated hiPSCs [5,21].”
BackgroundMethodInfluentialTakata, M., Nishimura, K., Harada, K., Iwasaki, R., Ando, M., Yamada, S., Ginhoux, F., & Takata, K. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102023 · Cited by 18
Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
Murai, N., Koyanagi‐Aoi, M., Terashi, H., & Aoi, T. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.02.010 · Cited by 16
“Stem Ce This is an open access arti expansion during 100 days ( 10,000-fold/2 weeks) (Nakagawa et al., 2014).”
BackgroundKaini, R. R., Shen-Gunther, J., Cleland, J. M., Greene, W. A., & Wang, H.-C. H. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0180 · Cited by 17
“In the interest of developing xeno-free protocols, several research groups have identified potential replacements for MEF feeder cells or Matrigel.(35,36,40) In one study, vitronectin was found to support self-renewal and pluripotency by interacting with integrin aVb5.”
Ntai, A., Baronchelli, S., Spada, A., Moles, A., Guffanti, A., Blasio, P. D., & Biunno, I. (2017) · Biopreservation and Biobanking · doi:10.1089/bio.2016.0097 · Cited by 15
Yuzuriha, A., Nakamura, S., Sugimoto, N., Kihara, S., Nakagawa, M., Yamamoto, T., Sekiguchi, K., & Eto, K. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102287 · Cited by 16
Kitagawa, Y., Kawasaki, Y., Yamasaki, Y., Kambe, N., Takei, S., & Saito, M. K. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.030 · Cited by 16
Takenaka, C., Miyajima, H., Yoda, Y., Imazato, H., Yamamoto, T., Gomi, S., Ohshima, Y., Kagawa, K., Sasaki, T., & Kawamata, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129855 · Cited by 17
Li, P., Wang, S., Zhan, L., He, X., Chi, G., Lv, S., Xu, Z., Xia, Y., Teng, S., Li, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10428-5 · Cited by 19
Nakamura, T., Morishige, S., Ozawa, H., Kuboyama, K., Yamasaki, Y., Oya, S., Yamaguchi, M., Aoyama, K., Seki, R., Mouri, F., et al. (2020) · Haemophilia · doi:10.1111/hae.14104 · Cited by 16
Kimura, A., Toyoda, T., Iwasaki, M., Hirama, R., & Osafune, K. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.018 · Cited by 16
Human iPS cells engender corneal epithelial stem cells with holoclone-forming capabilities
Watanabe, S., Hayashi, R., Sasamoto, Y., Tsujikawa, M., Ksander, B. R., Frank, M. H., Quantock, A. J., Frank, N. Y., & Nishida, K. (2021) · iScience · doi:10.1016/j.isci.2021.102688 · Cited by 15
Canine induced pluripotent stem cell maintenance under feeder‐free and chemically‐defined conditions
Kimura, K., Tsukamoto, M., Yoshida, T., Tanaka, M., Kuwamura, M., Ohtaka, M., Nishimura, K., Nakanishi, M., Sugiura, K., & Hatoya, S. (2021) · Molecular Reproduction and Development · doi:10.1002/mrd.23478 · Cited by 15
Yamasaki, S., Kuwahara, A., Kishino, A., Kimura, T., Takahashi, M., & Mandai, M. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2021.12.003 · Cited by 16
“hESCs and hiPSCsweremaintained in StemFitmedium (Ajinomoto, Japan) in six-well tissue culture plates (AGC Techno Glass, Japan) coated with LM511-E8 matrix (iMatrix511, Matrixome, Japan) as previously described [24].”
MethodInfluentialNakatsu, D., Kunishige, R., Taguchi, Y., Shinozaki‐Narikawa, N., Osaka, K., Yokomizo, K., Ishida, M., Takei, S., Yamasaki, S., Hagiya, K., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.004 · Cited by 18
“were a kind gift from Kyoto University through the Riken Cell Biology Center (Okita et al., 2011, 2013; Nakagawa et al., 2014; Kondo et al., 2013, 2017).”
MethodYokoi, F., Deguchi, S., Watanabe, Y., & Takayama, K. (2024) · iScience · doi:10.1016/j.isci.2024.111049 · Cited by 18
Novosadova, E. V., & Grivennikov, I. A. (2014) · Biochemistry (Moscow) · doi:10.1134/s000629791413001x · Cited by 23
“Subsequently, a feederfree method was developed for propagation of human ES cells using Matrigel, CELLstart, and several other artificial substrates [7-9].”
MethodKitajima, R., Nakai, R., Imamura, T., Kameda, T., Kozuka, D., Hirai, H., Ito, H., Imai, H., & Imamura, M. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101749 · Cited by 14
Mondal, T., Das, K., Singh, P., Natarajan, M., Manna, B., Ghosh, A., Singh, P., Saha, S. K., Dhama, K., Dutt, T., et al. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102487 · Cited by 14
Supakul, S., Okano, H., & Maeda, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.768948 · Cited by 16
Gene therapy using genome‐edited iPS cells for targeting malignant glioma
Tamura, R., Miyoshi, H., Imaizumi, K., Yo, M., Kase, Y., Sato, T., Sato, M., Morimoto, Y., Sampetrean, O., Kohyama, J., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10406 · Cited by 14
“1210B2-hiPSCs (kindly provided by Shinya Yamanaka, Kyoto University, Kyoto, Japan) were cultured with a feeder-free protocol.(12,54) Embryoid body (EB) formation and neural stem/progenitor cell generation were performed as previously described.”
MethodHuman Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency
Hawkins, K., Moschidou, D., Faccenda, D., Wruck, W., Martín-Trujillo, Á., Hau, K.-L., Ranzoni, A. M., Sánchez-Freire, V., Tommasini, F., Eaton, S. D., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.014 · Cited by 15
“(a) Population distribution for 3 different VPA_AFS cell samples (S1, S2 and S3, 46 cells per sample) and hES cells showing heterogeneity in the expression of 12 genes associated with pluripotency (CDKN1A, CDKN2A, KLF5, NODAL, UTF1, GDF3, FOXD3, TERT, KLF2, DPPA2, DPPA5, and FGF4).”
MethodInfluentialSano, M., Ohtaka, M., Iijima, M., Nakasu, A., Kato, Y., & Nakanishi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12847-w · Cited by 15
Metadata
- Authors
- Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., Yoshida, Y., Toyoda, T., Osafune, K., Sekiguchi, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- Institute for Protein Research, The University of Osaka (JP)
- Ajinomoto (Japan) (JP)
- Gladstone Institutes (US)
- Corresponding author
- Nakagawa, Masato
- ORCID
- Venue
- Scientific Reports
- Published
- 2014-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 3594-3594
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3884228
- OpenAlex
- W1972564906
- Cited by
- 673
- References
- 30
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 74 · 2023: 66 · 2022: 65 · 2021: 76 · 2020: 66 · 2019: 49 · 2018: 37 · 2017: 58 · 2016: 47 · 2015: 39 · 2014: 14
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- OUKA (Osaka University Knowledge Archive) (Osaka University) (submittedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25860747, 24790277, 24590353, 24592124, 25291026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, feeder-free culture, xeno-free culture, human embryonic stem cells, primary fibroblasts, blood cells, karyotype stability, cell dissociation, differentiation potential
- MeSH terms
- Cell Differentiation, Culture Media, Humans, Serial Passage, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.